Clinical Trial Update: Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions [Phase 2]

View source ↗

Summary

Phase 2 trial of escitalopram (Lexapro) for traumatic brain injury–related depression and other psychiatric conditions completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Traumatic Brain Injury

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Johns Hopkins University | Conditions: TBI, Major Depression | Phase 2 | Status: COMPLETED | Results posted: 2016-10-24